Consensus MorphoSys AG

Equities

MOR

DE0006632003

Real-time Estimate Tradegate 07:05:02 2024-05-28 EDT 5-day change 1st Jan Change
67.92 EUR -0.26% Intraday chart for MorphoSys AG -0.66% +100.00%

Evolution of the average Target Price on MorphoSys AG

Price target over the last 5 years

History of analyst recommendation changes

42cbcc0eea89c4.jVGvf2MweWh-LkWhfvZ4SAjuE78zRm8SrvlVLH9JXYs.6h71M1RjEwc5GCfmGoMcMWWgfutVFiN-zJEDGzlkB7r9Pdc5EEQKAkpCfQ~aa1e2312597232b8df4d25307c386c4b
MORPHOSYS : UBS reiterates its Neutral rating ZD
MORPHOSYS : UBS remains Neutral ZD
Trending : Novartis Begins Tender Offer for MorphoSys Shares DJ
MORPHOSYS : UBS sticks Neutral ZD
Novartis' Midterm Sales Growth Prospects Limited as Patent Expirations Loom, Berenberg Says MT
MORPHOSYS : UBS revises his opinion and turns to Neutral ZD
MORPHOSYS : UBS remains its Buy rating ZD
Swiss Market Index Blinks Red Amid Renewed Rate Jitters MT
North American Morning Briefing : Rate Doubts Keep Pressure on Stocks; More Earnings in Focus DJ
MORPHOSYS : UBS reiterates its Buy rating ZD
European Midday Briefing : Stocks Higher But Gains Capped On Rate Doubts DJ
MORPHOSYS : JP Morgan reaffirms its Buy rating ZD
MORPHOSYS : UBS reiterates its Buy rating ZD
MORPHOSYS : Deutsche Bank sticks Neutral ZD
MORPHOSYS : JP Morgan gives a Buy rating ZD
UBS reiterates Morphosys at 'Buy' - Target 47 euros DP
MORPHOSYS : UBS remains its Buy rating ZD
MORPHOSYS : UBS reiterates its Buy rating ZD
Lower Bank Earnings, Higher Interest Rates Weigh on Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday MT
MORPHOSYS : JP Morgan reiterates its Buy rating ZD
MORPHOSYS : Receives a Buy rating from JP Morgan ZD
MORPHOSYS : Gets a Neutral rating from Goldman Sachs ZD
Wells Fargo Adjusts MorphoSys' Price Target to $17 From $10, Keeps Overweight Rating MT
MORPHOSYS : Deutsche Bank reiterates its Neutral rating ZD
MORPHOSYS : JP Morgan gives a Buy rating ZD
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
68.1 EUR
Average target price
58.71 EUR
Spread / Average Target
-13.78%
High Price Target
68 EUR
Spread / Highest target
-0.15%
Low Price Target
31 EUR
Spread / Lowest Target
-54.48%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MorphoSys AG

UBS
JPMORGAN James Gordon
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
GOLDMAN SACHS Rajan Sharma
Wells Fargo Securities
JPMorgan Chase
MORGAN STANLEY James Quigley
BERENBERG Xian Deng
DEUTSCHE BANK Rajan Sharma
BARCLAYS Brian Balchin
Deutsche Bank Securities
Commerzbank
STIFEL Marcus Wieprecht
SVB Leerink
Bryan, Garnier & Co.
INDEPENDENT RESEARCH Tobias Gottschalt
RBC Charles Weston
HSBC Julie Mead
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. MOR Stock
  4. Consensus MorphoSys AG